NPR February 29, 2024
Rob Stein

NEAR BLACKSBURG, Va. — It’s a crisp, clear winter day as I drive down a winding two-lane road through the foothills of the Blue Ridge Mountains in southwest Virginia and turn onto an unmarked gravel driveway.

At the end of the drive, I meet David Ayares, who runs Revivicor Inc., a biotech company based in Blacksburg, Virginia.

Ayares has invited me to be the first journalist to tour the company’s research farm, which is on the forefront of trying to realize a long-sought goal: using cloned farm animals to provide kidneys, hearts, livers and other organs to save thousands of people who need transplants.

“It’s exciting. We’ve been working on this for more than 20 years. And it’s no longer...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider
The biggest expenses crushing physician practices
Three ways the Trump administration could reinvest in rural America's future, starting with health care
Healthcare data breaches down in '24
Altru joins North Dakota hospital collaborative
'The future of hospital rooms': Inside UT Health's new $472M facility

Share This Article